“…As previously described 14 , 15 , uterine stromal cells from day 4 of pregnancy were isolated by enzymatic digestion followed by purity analysis with vimentin (a marker for stromal cells) and cytokeratin (a marker for epithelial cells) staining and then cultured with DMEM-F12 containing 10% heat-inactivated FBS (Clark, #25015). Meanwhile, stromal cells were treated with 10 nM of estradiol-17β (Sigma, #E1024, 10 nM) plus 1 μM of progesterone (Sigma, #850454, 1 μM) in DMEM-F12 containing 2% charcoal-treated FBS (Gibco, #12676-029) to in vitro decidualization which was verified as previously described 15 , 16 . For further analysis, cells were treated with Yap inhibitor Verteporfin (100 nm, R&D systems, #5305) in the absence or presence of recombinant murine Bmp2 protein (rBmp2, 100 ng/ml, Peprotech, #120-02), glutathione reductase (GR) inhibitor 1, 3-bis (2-chloroethyl)-1-nitrosourea (BCNU, 20 μM, Sigma, #154-93-8), GSH (1 mM, Beyotime, #S0073) and mitochondria-targeted antioxidant Mito-TEMPO (MCE, 10 mΜ, #HY-112879) under the context of in vitro decidualization.…”